District Court, D. Delaware March 27, 2007, Civ. A. 06-259-MPT (Amgen, Inc. v. Ariad Pharmaceuticals, Inc.)

Also known as

United States · · · 27-03-2007

MEMORANDUM OPINION

THYNGE, United States Magistrate Judge.

I. Introduction

On April 20, 2006, Amgen Inc. and related entities (collectively “Amgen”) filed a declaratory judgment action asserting that each claim of U.S. Patent No. 6,410,516 (“ ’516 patent”) is invalid.

Read the full text

This document is published by courtlistener.com.

Moonlit adds the citation network, article-level links and cross-references, which are available to search for free.